These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1221 related articles for article (PubMed ID: 2387772)
1. Isolation of cepafungins I, II and III from Pseudomonas species. Shoji J; Hinoo H; Kato T; Hattori T; Hirooka K; Tawara K; Shiratori O; Terui Y J Antibiot (Tokyo); 1990 Jul; 43(7):783-7. PubMed ID: 2387772 [TBL] [Abstract][Full Text] [Related]
2. Glidobactins A, B and C, new antitumor antibiotics. I. Production, isolation, chemical properties and biological activity. Oka M; Nishiyama Y; Ohta S; Kamei H; Konishi M; Miyaki T; Oki T; Kawaguchi H J Antibiot (Tokyo); 1988 Oct; 41(10):1331-7. PubMed ID: 3142840 [TBL] [Abstract][Full Text] [Related]
3. Verucopeptin, a new antitumor antibiotic active against B16 melanoma. I. Taxonomy, production, isolation, physico-chemical properties and biological activity. Nishiyama Y; Sugawara K; Tomita K; Yamamoto H; Kamei H; Oki T J Antibiot (Tokyo); 1993 Jun; 46(6):921-7. PubMed ID: 8344873 [TBL] [Abstract][Full Text] [Related]
4. Protactin, a new antibiotic metabolite and a possible precursor of the actinomycins. Hanada M; Sugawara K; Nishiyama Y; Kamei H; Hatori M; Konishi M J Antibiot (Tokyo); 1992 Jan; 45(1):20-8. PubMed ID: 1372309 [TBL] [Abstract][Full Text] [Related]
5. Himastatin, a new antitumor antibiotic from Streptomyces hygroscopicus. I. Taxonomy of producing organism, fermentation and biological activity. Lam KS; Hesler GA; Mattei JM; Mamber SW; Forenza S; Tomita K J Antibiot (Tokyo); 1990 Aug; 43(8):956-60. PubMed ID: 2211362 [TBL] [Abstract][Full Text] [Related]
6. Isolation of a new phenazine antibiotic, DOB-41, from Pseudomonas species. Shoji J; Sakazaki R; Nakai H; Terui Y; Hattori T; Shiratori O; Kondo E; Konishi T J Antibiot (Tokyo); 1988 May; 41(5):589-94. PubMed ID: 3384746 [TBL] [Abstract][Full Text] [Related]
7. Calicheamicins, a novel family of antitumor antibiotics: taxonomy, fermentation and biological properties. Maiese WM; Lechevalier MP; Lechevalier HA; Korshalla J; Kuck N; Fantini A; Wildey MJ; Thomas J; Greenstein M J Antibiot (Tokyo); 1989 Apr; 42(4):558-63. PubMed ID: 2722671 [TBL] [Abstract][Full Text] [Related]
8. Quinaldopeptin, a novel antibiotic of the quinomycin family. Toda S; Sugawara K; Nishiyama Y; Ohbayashi M; Ohkusa N; Yamamoto H; Konishi M; Oki T J Antibiot (Tokyo); 1990 Jul; 43(7):796-808. PubMed ID: 2387774 [TBL] [Abstract][Full Text] [Related]
9. New antifungal antibiotics, pradimicins D and E. Glycine analogs of pradimicins A and C. Sawada Y; Nishio M; Yamamoto H; Hatori M; Miyaki T; Konishi M; Oki T J Antibiot (Tokyo); 1990 Jul; 43(7):771-7. PubMed ID: 2387770 [TBL] [Abstract][Full Text] [Related]
10. Antineoplastic activity of didemnin congeners: nordidemnin and modified chain analogues. Jouin P; Poncet J; Dufour MN; Aumelas A; Pantaloni A; Cros S; François G J Med Chem; 1991 Feb; 34(2):486-91. PubMed ID: 1995869 [TBL] [Abstract][Full Text] [Related]
12. New antitumor antibiotic, FR-900462. II. Production, isolation, characterization and biological activity. Iwami M; Nakayama O; Okuhara M; Terano H; Kohsaka M J Antibiot (Tokyo); 1989 May; 42(5):686-90. PubMed ID: 2722682 [TBL] [Abstract][Full Text] [Related]
13. Eponemycin, a new antibiotic active against B16 melanoma. I. Production, isolation, structure and biological activity. Sugawara K; Hatori M; Nishiyama Y; Tomita K; Kamei H; Konishi M; Oki T J Antibiot (Tokyo); 1990 Jan; 43(1):8-18. PubMed ID: 2106503 [TBL] [Abstract][Full Text] [Related]
14. Kazusamycin B, a novel antitumor antibiotic. Funaishi K; Kawamura K; Sugiura Y; Nakahori N; Yoshida E; Okanishi M; Umezawa I; Funayama S; Komiyama K J Antibiot (Tokyo); 1987 Jun; 40(6):778-85. PubMed ID: 3610834 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and cytostatic activity of the antitumor antibiotic chartreusin derivatives. Kon K; Sugi H; Tamai K; Ueda Y; Yamada N J Antibiot (Tokyo); 1990 Apr; 43(4):372-82. PubMed ID: 2351612 [TBL] [Abstract][Full Text] [Related]
16. Hydramycin, a new antitumor antibiotic. Taxonomy, isolation, physico-chemical properties, structure and biological activity. Hanada M; Kaneta K; Nishiyama Y; Hoshino Y; Konishi M; Oki T J Antibiot (Tokyo); 1991 Aug; 44(8):824-31. PubMed ID: 1833366 [TBL] [Abstract][Full Text] [Related]
17. SW-163C and E, novel antitumor depsipeptides produced by Streptomyces sp. I. Taxonomy, fermentation, isolation and biological activities. Kurosawa K; Takahashi K; Tsuda E J Antibiot (Tokyo); 2001 Aug; 54(8):615-21. PubMed ID: 11592497 [TBL] [Abstract][Full Text] [Related]
18. Experimental antitumor activity and toxicity of a new chemotherapeutic agent, BBM 928A. Rose WC; Schurig JE; Huftalen JB; Bradner WT Cancer Res; 1983 Apr; 43(4):1504-10. PubMed ID: 6831399 [No Abstract] [Full Text] [Related]
19. Sandramycin, a novel antitumor antibiotic produced by a Nocardioides sp. Production, isolation, characterization and biological properties. Matson JA; Bush JA J Antibiot (Tokyo); 1989 Dec; 42(12):1763-7. PubMed ID: 2621159 [TBL] [Abstract][Full Text] [Related]
20. Porothramycin, a new antibiotic of the anthramycin group: production, isolation, structure and biological activity. Tsunakawa M; Kamei H; Konishi M; Miyaki T; Oki T; Kawaguchi H J Antibiot (Tokyo); 1988 Oct; 41(10):1366-73. PubMed ID: 3192492 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]